Here are four insights:
1. Baird previously rated the company as “neutral.”
2. On April 15, Exactech’s stock ended at $21.96.
3. The company’s 52-week high is $25.74 and the 52-week low is $16.11.
4. Exactech has a market capitalization of $308 million.
More articles on devices:
Orthofix shares reach new 1-year high: 3 points
1k Hunter Medical’s ElbowLOC Arm Positioning System procedures complete: 3 notes
Dr. Robert Rovner uses Coflex as an alternative treatment for spinal stenosis — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
